EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Financial resources, access to care, and quality of care mediate racial disparities in statin usage for secondary prevention

Christopher Wong iD, Lyndonna Marrast, Rehana Rasul, Ratnam Srivastava, Jeffrey Kuvin, Robert Roswell iD, Joseph Conigliaro, Eun Ji Kim

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0311724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Christopher Wong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Rutgers Robert Wood Johnson School of Medicine, New Brunswick, New Jersey, United States of America. Hauptthemen laut MEDLINE: Health Services Accessibility, Healthcare Disparities, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Quality of Health Care. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are disparities in statin therapy for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD). The role of structural racism in this disparity has not been examined.

Methods

This is a cross-sectional study of participants with ASCVD in the Medical Expenditure Panel Survey from 2014–2017. Mediation analysis is utilized to estimate the direct effect of race and indirect effect of financial resources, access to care, and quality of care on statin usage.

Results

The proportion of participants using statins by race/ethnicity were 58.5% for non-Hispanic Whites, 45% for Hispanics, 48.6% for Blacks, 61.6% for Asians, and 46.8% for Others. Statin usage was lower for Hispanics (OR = 0.79, 95% confidence interval [0.65–0.96]) and Blacks (OR = 0.80 [0.66–0.95]) compared to Whites. Hispanic, Black, and Other participants with the same financial resources, access to care, and quality of care as White participants did not have significantly different statin usage compared to White participants (Hispanic: OR = 0.98 [0.79–1.13]; Black (OR = 0.88 [0.76–1.06], Other: OR 0.76, 95% CI [0.56–1.15]). Hispanic, Black, and Other participants had significantly lower statin usage than subjects of the same race but with financial resources, access to care, and quality of care observed in White subjects (Hispanic: OR = 0.83 [0.83–0.92]; Black: OR = 0.91[0.88–0.94]; Other: OR = 0.92 [0.87–0.98]).

Discussion

The indirect effect of race and ethnicity on statin therapy are significant but the direct effect of race and ethnicity on statin therapy are insignificant among Blacks and Hispanics compared to non-Hispanic Whites. This suggests that racial disparities in statin therapy are mediated through inequitably distributed resources, suggestive of the impact of structural racism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health Services AccessibilityHealthcare DisparitiesHydroxymethylglutaryl-CoA Reductase InhibitorsQuality of Health CareSecondary PreventionAdultAgedFemaleHumansMaleMiddle AgedAtherosclerosisCross-Sectional StudiesHispanic or LatinoUnited StatesWhiteBlack or African American

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Division of Cardiology, Rutgers Robert Wood Johnson School of Medicine, New Brunswick, New Jersey, United States of America.
  • Division of General Internal Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lake Success, New York, United States of America.
  • Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York, New York, New York, United States of America.
  • Department of Cardiology, Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York, United States of America.
  • Lennox Hill Hospital, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States of America.

ORCID-Profile: Christopher Wong, Robert Roswell

Zitieren

APA

Wong, C., Marrast, L., Rasul, R., Srivastava, R., Kuvin, J., Roswell, R., Conigliaro, J., & Kim, E. J. (2024). Financial resources, access to care, and quality of care mediate racial disparities in statin usage for secondary prevention. PLOS ONE. https://doi.org/10.1371/journal.pone.0311724

Vancouver

Wong C, Marrast L, Rasul R, Srivastava R, Kuvin J, Roswell R, et al. Financial resources, access to care, and quality of care mediate racial disparities in statin usage for secondary prevention. PLOS ONE. 2024. doi:10.1371/journal.pone.0311724

BibTeX
@article{Wong2024,
  author = {Wong, Christopher and Marrast, Lyndonna and Rasul, Rehana and Srivastava, Ratnam and Kuvin, Jeffrey and Roswell, Robert and Conigliaro, Joseph and Kim, Eun Ji},
  title = {Financial resources, access to care, and quality of care mediate racial disparities in statin usage for secondary prevention},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0311724}
}
Kostenlos starten →